You just read:

Clene Nanomedicine Awarded Research Grant from the National Multiple Sclerosis Society to Support Clinical Development of its Lead Nanocatalytic Therapeutic, CNM-Au8

News provided by

Clene Nanomedicine, Inc.

Oct 14, 2019, 08:00 ET